| Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells | Blood | 2004 | 366 |
| Differential prognostic impact of comorbidity | Journal of Clinical Oncology | 2004 | 265 |
| Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing | Proceedings of the National Academy of Sciences of the United States of America | 2004 | 157 |
| Microdeletion of LIT1 in familial Beckwith-Wiedemann syndrome | American Journal of Human Genetics | 2004 | 113 |
| The inositol polyphosphate 5-phosphatase Ocrl associates with endosomes that are partially coated with clathrin | Proceedings of the National Academy of Sciences of the United States of America | 2004 | 112 |
| Mutations of the SBDS gene are present in most patients with Shwachman-Diamond syndrome | Blood | 2004 | 86 |
| Asthma and acute chest in sickle-cell disease | Pediatric Pulmonology | 2004 | 80 |
| A global suppressor motif for p53 cancer mutants | Proceedings of the National Academy of Sciences of the United States of America | 2004 | 73 |
| Dyskeratosis congenita and telomerase | Current Opinion in Pediatrics | 2004 | 45 |
| Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding | Circulation | 2004 | 44 |
| Identification of a 4-base deletion in the gene in inherited intrinsic factor deficiency | Blood | 2004 | 38 |
| A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria | BMC Hematology | 2004 | 24 |
| A novel mechanism of complement-independent clearance of red cells deficient in glycosyl phosphatidylinositol-linked proteins | Blood | 2004 | 22 |
| Mutation in the leucine-rich repeat C-flanking region of platelet glycoprotein Ib beta impairs assembly of von Willebrand factor receptor | Thrombosis and Haemostasis | 2004 | 17 |
| Transcranial Doppler Changes in Children With Sickle Cell Disease on Transfusion Therapy | Journal of Pediatric Hematology/Oncology | 2004 | 13 |
| Hypopigmentation from imatinib mesylate (Gleevec) | Journal of Pediatric Hematology/Oncology | 2004 | 12 |
| Does heparin cofactor II modulate atherosclerosis and restenosis? | Circulation | 2004 | 11 |
| A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC) | Journal of Clinical Oncology | 2004 | 8 |
| Phase II Trials of Clofarabine in Relapsed or Refractory Pediatric Leukemia. | Blood | 2004 | 7 |
| G-CSF induced progenitor mobilization in mice with PIGA- blood cells | The Hematology Journal | 2004 | 4 |
| Heterozygous telomerase deficiency in mouse and man: when less is definitely not more | Cell Cycle | 2004 | 4 |
| Reduced Intensity Conditioning Therapy Using Campath -1H Is Successful for Stem Cell Transplantation in Non-Malignant Disorders. | Blood | 2004 | 3 |
| Successful Gene Therapy of Murine Paroxysmal Nocturnal Hemoglobinuria (PNH) Using Mgmt-Mediated In Vivo Selection of Genetically Corrected, Drug-Resistant Hematopoietic Stem Cells. | Blood | 2004 | |
